DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

O'Brien S, Furman RR, Coutre S. et al.
Single-agent ibrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience.

Blood 2018;
131: 1910-1919

Download Bibliographical Data

Search in:
Access: